Fosun Pharma unit starts China Phase II trial of COPD drug candidate FXS7553PUBT·Aug 13 at 04:38 AM02196-2.96%600196-5.15%
Fosun Pharma Subsidiary Wins Approval for Pediatric Constipation Drug in ChinaTip Ranks·Aug 3 at 05:13 AM02196-2.96%600196-5.15%
Fosun International Issues 1H2026 Positive Profit Alert as Core Industries Show Strong ResilienceAsian Corporate Newswire·Jul 30 at 07:35 PM00656+2.45%02196-2.96%
Fosun expects 1H profit attributable to owners at RMB 1.5 billion-RMB 1.8 billionPUBT·Jul 29 at 04:33 AM02196-2.96%00656+2.45%
Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian marketsPUBT·Jul 16 at 06:33 AMVRAX-7.54%02196-2.96%
Fosun Pharma Shenzhen wins China approval to start Phase I trial of FXR0906 for hypertriglyceridemiaPUBT·Jul 15 at 05:14 AM02196-2.96%600196-5.15%
Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Gets a Hold from HSBCTip Ranks·Jul 13 at 07:27 PM600196-5.15%02196-2.96%
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watchrttnews·Jul 9 at 09:55 PMFBRX+0.04%CNTB+3.51%
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics | VRAX Stock NewsStockTitan·Jul 8 at 10:30 PMVRAX-7.54%02196-2.96%
